Delphi study among international expert panel to develop waterpipe-specific health warning labels.
global health
packaging and labelling
public policy
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
03
09
2018
revised:
20
11
2018
accepted:
20
12
2018
pubmed:
31
1
2019
medline:
2
6
2021
entrez:
31
1
2019
Statut:
ppublish
Résumé
Waterpipe (WP) smoking is increasing globally. The rise of WP has been fuelled by widespread misperception of reduced-harm compared to cigarettes. Health warning labels (HWLs) are one strategy to communicate smoking-related risks and address reduced-harm misperceptions. Therefore, the development of WP-specific HWLs represents a priority for WP control. A panel of experts in WP science developed 28 WP-specific HWLs corresponding to five themes (health risks, addiction, harm to others, WP-specific harm, WP harm compared to cigarettes). Subsequently, a three-round Delphi study was conducted among international expert panel to reach consensus on a set of the most effective HWLs for each theme. Levels of agreement between participants were assessed using interquartile deviations, and the rank between the tied HWLs was based on the median. Starting with 28 candidate HWLs stratified according to five WP-related themes, our international expert panel reached consensus on the 13 most important WP-specific HWLs. Labels with the highest agreement were related to oral and heart disease, WP's harmful effects on newborn children and the amount of smoke inhaled from WP compared to cigarettes. This study is the first to systematically develop and evaluate potential WP-specific HWLs based on the scientific evidence about WP's harmful effects, scientific understanding of HWL for cigarettes and the opinions of experts in WP science, tobacco control and health communication. The final selected HWLs can be adapted based on the context and policy landscape of the target country and can be further fine-tuned based on feedback from WP smokers and non-smokers.
Sections du résumé
BACKGROUND
Waterpipe (WP) smoking is increasing globally. The rise of WP has been fuelled by widespread misperception of reduced-harm compared to cigarettes. Health warning labels (HWLs) are one strategy to communicate smoking-related risks and address reduced-harm misperceptions. Therefore, the development of WP-specific HWLs represents a priority for WP control.
METHODS
A panel of experts in WP science developed 28 WP-specific HWLs corresponding to five themes (health risks, addiction, harm to others, WP-specific harm, WP harm compared to cigarettes). Subsequently, a three-round Delphi study was conducted among international expert panel to reach consensus on a set of the most effective HWLs for each theme. Levels of agreement between participants were assessed using interquartile deviations, and the rank between the tied HWLs was based on the median.
RESULTS
Starting with 28 candidate HWLs stratified according to five WP-related themes, our international expert panel reached consensus on the 13 most important WP-specific HWLs. Labels with the highest agreement were related to oral and heart disease, WP's harmful effects on newborn children and the amount of smoke inhaled from WP compared to cigarettes.
CONCLUSION
This study is the first to systematically develop and evaluate potential WP-specific HWLs based on the scientific evidence about WP's harmful effects, scientific understanding of HWL for cigarettes and the opinions of experts in WP science, tobacco control and health communication. The final selected HWLs can be adapted based on the context and policy landscape of the target country and can be further fine-tuned based on feedback from WP smokers and non-smokers.
Identifiants
pubmed: 30696784
pii: tobaccocontrol-2018-054718
doi: 10.1136/tobaccocontrol-2018-054718
pmc: PMC6663656
mid: NIHMS1012984
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-167Subventions
Organisme : FIC NIH HHS
ID : R01 TW010654
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Références
Salud Publica Mex. 2007;49 Suppl 2:S233-40
pubmed: 17607485
Ugeskr Laeger. 2014 Oct 27;176(44):
pubmed: 25353998
Fed Regist. 2011 Jun 22;76(120):36628-777
pubmed: 21696017
Am J Drug Alcohol Abuse. 2015;41(4):272-80
pubmed: 26057153
J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1481-4
pubmed: 25677592
Tob Control. 2015 Mar;24 Suppl 1:i1-i2
pubmed: 25618894
Semin Arthritis Rheum. 2011 Oct;41(2):95-105
pubmed: 21420149
Med Care. 1996 Jun;34(6):512-23
pubmed: 8656718
Tob Control. 2016 May;25(3):341-54
pubmed: 25948713
Aust Health Rev. 2016 Apr;40(2):155-162
pubmed: 26364314
PLoS One. 2013;8(3):e58516
pubmed: 23505526
Nicotine Tob Res. 2012 Jan;14(1):62-74
pubmed: 22039072
Am J Public Health. 2016 Oct;106(10):1773-7
pubmed: 27552262
Soc Sci Med. 2016 Sep;164:118-129
pubmed: 27423739
Int J Public Health. 2017 Jan;62(1):73-83
pubmed: 27421466
Tob Control. 2017 Jan;26(1):92-97
pubmed: 27165994
Am J Epidemiol. 1998 Aug 15;148(4):375-83
pubmed: 9717882
Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2345-53
pubmed: 21908725
BMJ Open. 2015 Sep 09;5(9):e009497
pubmed: 26353876
Nicotine Tob Res. 2018 Jan 5;20(2):154-160
pubmed: 27798091
Tob Control. 2015 Mar;24 Suppl 1:i44-i53
pubmed: 25492935
BMJ Open. 2015 Apr 15;5(4):e007197
pubmed: 25877274
Tob Control. 2010 Jun;19(3):235-9
pubmed: 20501497
Biomed Res Int. 2015;2015:745865
pubmed: 26273642
Am J Prev Med. 2012 Dec;43(6):590-600
pubmed: 23159254
JAMA Intern Med. 2016 Jul 1;176(7):905-12
pubmed: 27273839
Nicotine Tob Res. 2014 Jul;16(7):961-75
pubmed: 24590387
Tob Control. 2011 Sep;20(5):327-37
pubmed: 21606180
J Am Dent Assoc. 2015 Oct;146(10):760-6
pubmed: 26409986
J Health Serv Res Policy. 1999 Oct;4(4):236-48
pubmed: 10623041
Int J Environ Res Public Health. 2013 May 24;10(6):2120-32
pubmed: 23708049
BJOG. 2008 Jan;115(1):91-7
pubmed: 18053105
Cancer Causes Control. 2012 Mar;23 Suppl 1:57-67
pubmed: 22362058
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Tob Control. 2019 Jul;28(4):475-478
pubmed: 29980654
Tob Control. 2009 Feb;18(1):34-42
pubmed: 18845621
Int J Environ Res Public Health. 2015 May 29;12(6):6115-35
pubmed: 26110330
Health Policy Plan. 2014 Sep;29(6):784-94
pubmed: 23958628
BMJ. 2015 Apr 17;350:h1991
pubmed: 25888390
J Psychoactive Drugs. 2011 Apr-Jun;43(2):146-52
pubmed: 21858960
Tob Control. 1999 Summer;8(2):137-40
pubmed: 10478396
Int J Public Health. 2016 Jul;61(6):709-715
pubmed: 26971508
Am J Health Behav. 2010 May-Jun;34(3):275-85
pubmed: 20001185
Tob Control. 2015 Mar;24 Suppl 1:i31-i43
pubmed: 25661414
Tob Control. 2018 May;27(3):347-351
pubmed: 28667092
Asian Pac J Cancer Prev. ;18(2):495-502
pubmed: 28345836
Epidemiol Health. 2018 Mar 13;40:e2018008
pubmed: 29529859
BMJ Open. 2018 Jul 13;8(7):e021983
pubmed: 30007932
Int J Tuberc Lung Dis. 2012 Jan;16(1):132-7
pubmed: 22236859
Patient Educ Couns. 2006 May;61(2):173-90
pubmed: 16122896
Nicotine Tob Res. 2019 Jun 21;21(7):855-862
pubmed: 29444268
PLoS One. 2015 Dec 16;10(12):e0142879
pubmed: 26672982
PLoS One. 2018 Feb 9;13(2):e0192191
pubmed: 29425207
Tob Control. 2013 May;22(e1):e57-65
pubmed: 22752271
Int J Epidemiol. 2017 Dec 1;46(6):1968-1977
pubmed: 29025018
Am J Prev Med. 2017 Apr;52(4):507-512
pubmed: 27890515